Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension
NCT: NCT01471834 · ACTIVE_NOT_RECRUITING
Реклама
NCT IDNCT01471834
СтатусACTIVE_NOT_RECRUITING
SponsorCVRx, Inc. (INDUSTRY)
First posted
Last updated
Краткое описание
To assess the long-term safety and efficacy of the BAROSTIM NEO System in trial (NCT01471834) participants.
Официальный источник
Открыть на ClinicalTrials.gov →Данные получены через API ClinicalTrials.gov. Актуальный статус смотрите в официальной записи.